The sleeping giant: protecting your at-risk patients from the pain of shingles

AUS

$0

free

RACGP CPD Program

1 hr

Infectious Disease, Screening & Prevention

2 Credits

Course Description

This 1-hour accredited program will help GPs understand the significant burden of shingles in Australia, including the risks of post-herpetic neuralgia (PHN) and stroke, and the rationale for vaccination. The program will support clinicians in proactively identifying individuals aged ≥50 years who may benefit from shingles vaccination, such as those with diabetes, and assist them in managing shingles vaccination in the context of immunosuppressive therapies.

Featuring three cases studies and expert video questions, this program highlights the importance of identifying patients who will benefit from shingles vaccination.


This educational activity was developed by MDBriefCase at the request, and with funding from Seqirus.

Course Details

Expiry Date: 2021-12-31

Professions: Physician

Faculty

Professor Paul Van Buynder
MBBS, MPH, FAFPHM

Associate Professor John Litt
MBBS MSc (Clin Epid), PhD, FRACGP, FAFPHM,
Flinders University, SA

Accreditation

This Active Learning Module has been approved by RACGP CPD Program for 2 CPD points.

Activity no. 221619

Members are able to claim CPD activity points for 2 points through ‘Quick log’ on their RACGP CPD Dashboard.

Learning Objective(s)

Upon completion of this continuing education program participants will be better able to:

  • Describe the significant burden of shingles in Australia and the rationale for vaccination.
  • Proactively identify individuals aged ≥50 years who may benefit from shingles vaccination such as those with diabetes.
  • Describe the latest evidence on the role of shingles vaccination in preventing post-herpetic neuralgia and stroke.
  • Manage shingles vaccination in the context of immunosuppressive therapies.